Gleevec Interactions
There are 744 drugs known to interact with Gleevec (imatinib), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 135 are major, 585 are moderate, and 24 are minor.
- View all 744 medications that may interact with Gleevec
- View Gleevec alcohol/food interactions (1)
- View Gleevec disease interactions (7)
Most frequently checked interactions
View interaction reports for Gleevec (imatinib) and the medicines listed below.
- allopurinol
- allopurinol
- aspirin
- aspirin
- atorvastatin
- atorvastatin
- Cymbalta (duloxetine)
- Cymbalta (duloxetine)
- furosemide
- furosemide
- gabapentin
- gabapentin
- Lasix (furosemide)
- Lasix (furosemide)
- levothyroxine
- levothyroxine
- lisinopril
- lisinopril
- metformin
- metformin
- metoprolol
- metoprolol
- omeprazole
- omeprazole
- pantoprazole
- pantoprazole
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zofran (ondansetron)
Gleevec alcohol/food interactions
There is 1 alcohol/food interaction with Gleevec (imatinib).
Gleevec disease interactions
There are 7 disease interactions with Gleevec (imatinib) which include:
- cardiovascular disease
- fluid retention
- bone marrow suppression
- gastrointestinal disorders
- hepatic impairment
- hypothyroidism
- renal impairment
More about Gleevec (imatinib)
- Gleevec consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.